Literature DB >> 200566

Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation.

R W Worthington, M S Mülders.   

Abstract

Enzymatic activation of Clostridium perfringens epsilon prototoxin removed a small basic part of the molecule, causing a slight change in molecular weight (32,700 to 31,200) and a large change in isoelectric point (from pH 8.02 into fractions of 5.36 and 5.74).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200566      PMCID: PMC421267          DOI: 10.1128/iai.18.2.549-551.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  1 in total

1.  Studies on epsilon-prototoxin of Clostridium perfringens type D. I. Purification methods: evidence for multiple forms of epsilon-prototoxin.

Authors:  A F Habeeb
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

  1 in total
  13 in total

1.  Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli.

Authors:  S E Hunter; I N Clarke; D C Kelly; R W Titball
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Identification of tyrosine 71 as a critical residue for the cytotoxic activity of Clostridium perfringens epsilon toxin towards MDCK cells.

Authors:  Zhigang Jiang; Jitao Chang; Fang Wang; Li Yu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

3.  F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability.

Authors:  Jingjing Kang; Jie Gao; Wenwu Yao; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Jiahao Yao; Wenwen Xin; Baohua Zhao; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-17       Impact factor: 3.452

4.  A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

Authors:  Qing Li; Wenwen Xin; Shan Gao; Lin Kang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

5.  Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1.

Authors:  Susan E Ivie; Mark S McClain
Journal:  Biochemistry       Date:  2012-09-12       Impact factor: 3.162

6.  Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

Review 7.  Clostridium perfringens type A-E toxin plasmids.

Authors:  John C Freedman; James R Theoret; Jessica A Wisniewski; Francisco A Uzal; Julian I Rood; Bruce A McClane
Journal:  Res Microbiol       Date:  2014-10-02       Impact factor: 3.992

8.  Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats.

Authors:  J Sakurai; M Nagahama; Y Fujii
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.

Authors:  Kareem Rashid Rumah; Yinghua Ma; Jennifer R Linden; Myat Lin Oo; Josef Anrather; Nicole Schaeren-Wiemers; Miguel A Alonso; Vincent A Fischetti; Mark S McClain; Timothy Vartanian
Journal:  PLoS Pathog       Date:  2015-05-20       Impact factor: 6.823

10.  Clostridium Perfringens Toxins Involved in Mammalian Veterinary Diseases.

Authors:  F A Uzal; J E Vidal; B A McClane; A A Gurjar
Journal:  Open Toxinology J       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.